We examined the biological activities present in Streptomyces strains preserved at the National Institute of Technology and Evaluation Biological Resource Center, and found a metabolite of Streptomyces roseolilacinus NBRC 12815 that showed a potent anti-tyrosinase activity. The compounds with anti-tyrosinase activity were purified by several chromatographic procedures. Final HPLC analysis revealed at least two anti-tyrosinase compounds with different retention times (12815A and B). The identification of two anti-tyrosinase compounds was performed with instrumental analysis and database search. The results obtained suggest that the active compounds are SF 2583A and B. Compound 12815A (IC 50 values; about 9 m mM) showed more potent tyrosinase inhibition than compound 12815B (IC 50 values; about 1086 m mM). The only structural difference between 12815A and B is the presence of an additional chloric atom. In addition, the activity of 12815A was markedly decreased under acidic conditions, resulting in irreversible inactivation. However, the inactivated 12815A still exhibited residual activity when exposed to detergent, Tween 80. These results suggest that the chlorine and the hydration water are very important in the exertion of anti-tyrosinase activity by 12815A.
which are the initial steps in melanin biosynthesis. 2) The melanin product that accumulates as a result of the enzymatic oxidation of L-tyrosine causes a decrease in the nutritional quality and loss in economic value of food products. On the other hand, the usage of tyrosinase inhibitors has used not only in the food, cosmetic and medical industries 3) but also in the agricultural chemicals. 4) In addition, the tyrosinase inhibition is expected to become a new target of fungicidal activity. 5) A number of tyrosinase inhibitors have been isolated from both natural and synthetic sources. 6) Compounds such as ascorbic acid and its derivatives, 7, 8) 4-hexylresorcinol, 9) arbutin, 10) kojic acid 11) and tricyclazole 4) have been utilized as skin-whitening agents, food additives and agricultural chemicals. Thus tyrosinase inhibitors have a wide range of usage in the various industries. One of the most useful of tyrosinase inhibitor is treatment and prevention of hyperpigmentation in human skin by which defects in melanin biosynthesis course. However, the most widely used compounds, such as kojic acid and arbutin, failed to demonstrate the clinical efficacy. 12) Therefore, there is a strong need to develop a new tyrosinase inhibitor.
We have previously investigated the taxonomical distribution of the Streptomyces species that are capable of producing bioactive compounds and reported our study on secondary metabolites of these microorganisms. 13) In this study, we found that S. roseolilacinus NBRC 12815 produces a metabolite (12815A) that exhibits potent anti-tyrosinase activity, though 12815A was a known-compound with antinematoda activity 14) and cytotoxicity. 15) Since it has been reported that 12815A has cytotoxic activity, 12815A may be not able to be developed as a tyrosinase inhibitor in itself. However, understanding the physiological characters of 12815A may offer a suggestion as a lead compound of tyrosinase inhibitors. Therefore, we report the anti-tyrosinase activity and the physicochemical characters of 12815A.
MATERIALS AND METHODS
Materials L-DOPA, a mushroom tyrosinase, indole, and a melanocyte-stimulating hormone (aMSH) were purchased from Sigma-Aldrich (St. Luis, MO, U.S.A.). Oxazole and 3-methylindole were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Dulbecco's modified Eagle's medium (DMEM) and Antibiotic-Antimycotic solution were purchased from Gibco (Grand Island, NY, U.S.A.). All the reagents used were of the highest commercially available grade.
Fermentation and Purification of Tyrosinase Inhibitors Purification procedures of tyrosinase inhibitors from S. roseolilacinus NBRC 12815 are illustrated in Fig. 1 . Strain NBRC 12815 was cultured at 28°C for 5 d in 500-ml Erlenmeyer flasks containing 100 ml of medium consisting of 2.5% starch, 1.5% soy bean meal, 0.2% dry yeast, and 0.4% CaCO 3 (pH 6.2 before sterilization). The whole culture broth (1 l) was centrifuged, and the mycelial cake was extracted with methanol (200 ml). After centrifugation at 5000ϫg for 10 min at 4°C, the supernatant was concentrated by evaporation. The methanol extract was applied to a Sephadex LH-20 column (2ϫ30 cm) (Pharmacia, Uppsala, Sweden) equilibrated and eluted with methanol. The tyrosinase inhibitory activity of each fraction (2 ml per tube) was measured. After gel filtration, the fractions with anti-tyrosinase activity were pooled and concentrated by evaporation. The active fraction was then applied to InertSep C18-C (GL Sciences, Tokyo, Japan) with a MeOH-H 2 O stepwise gradient system (10-100%). The 70% methanol elution was filtered through 0.22 mm filters (Millipore, Tokyo, Japan) and applied to an ODS C-18 column (10ϫ250 mm, YMC-Pack Pro C18 YMC, Co., Ltd., Kyoto, Japan) for a reversed-phase high performance liquid chromatography (HPLC) using a Waters 2695 LC system (Waters Co., Milford, MA, U.S.A.). Two mobile phase solvents were used; solvent A was prepared by adding 0.1% formic acid to deionized water, and solvent B was prepared by adding 0.1% formic acid to methanol. After a 5-min flow with 90% buffer A, a 35-min linear gradient to 100% buffer B was run at a flow rate of 1 ml/min and the elution was monitored at 254 nm. Analysis of 12815A and B was performed using a three-dimensional (3D) chromatogram by Millennium32 PDA Software (Waters). LC/MS LC separations were performed with a Waters 2695 LC system (Waters). An Inertsil ODS-2 column (5 mm, 1.5ϫ250 mm) (GL Sciences) set to a flow rate of 0.1 ml/min was used. Mobile phase solvents were used as described earlier. LC/MS analyses were performed on a micromass ZQ machine (Waters) equipped with an electrospray ionization (ESI) source. The HPLC eluate was loaded directly into the ion source. The sample was ionized by a positive ESI mode with desolvation temperature of 350°C, source block temperature of 120°C and cone voltage at 35 V. The ionization was monitored using a MassLynx TM NT operating system. The absorption spectrum of purified sample was measured using a Spectra max Plus 384 spectrophotometer (Molecular Devices Co., Tokyo, Japan) over the range of 200-500 nm. NMR 1 H, 13 C, and 2D NMR data were run on a Jeol A500 instrument. The data were obtained in CDCl 3 (Table 1) and also in CD 3 OD for comparison with those reported. 16) Chemical shifts were referenced to tetramethylsilane (TMS).
Assay of Inhibitory Activity towards Mushroom Tyrosinase Stock solutions of 1% 12815A and B were prepared in dimethylsulfoxide (DMSO). The samples were diluted in DMSO or water for experimental use, with DMSO alone as control. Tyrosinase activity was determined as described previously 17) with a minor modification. Briefly, 25 ml of L-DOPA (at a final concentration of 2.5 mM), 10 ml of sample (dissolved in DMSO), and 40 ml of 100 mM phosphate buffer (pH 6.8) were added to a 96-well microplate (Nunc, Denmark) and incubated at 25°C for 10 min. After incubation, 25 ml of an aqueous solution of mushroom tyrosinase (at a final concentration of 25 units/ml) was added. The assay mixture was incubated at 25°C for 30 min. Enzyme activity was quantified by measuring the absorbance at 475 nm. The Michaelis constant (K m ) and inhibitor constant (K i ) of the tyrosinase were determined by a Lineweaver-Burk plot for various concentrations of L-DOPA.
Assay of Inhibitory Activity towards Tyrosinase in B16 Melanoma Cells Mouse B16 melanoma cells were cultured in DMEM containing 10% FBS and Antibiotic-Antimycotic solution (Gibco) in 75 cm 2 flasks in a CO 2 incubator. To measure inhibitory activity against the mammalian tyrosinase, B16 cells were cultured at 1ϫ10 5 cells per well on a 6-well plate. The cells were harvested by trypsinization, washed three times with cold phosphate buffer saline (PBS) and centrifuged at 1000ϫg for 5 min. The cells were lysed in 0.1 M sodium phosphate buffer (pH 7.0) containing 1% Triton X-100 and 0.1 mM phenylmethylsulfonyl fluoride (PMSF). The cells sonicated three times on ice using a microprobe sonicator for 10 s each time. The Triton X-100-soluble fraction was separated by centrifugation at 21000ϫg for 15 min. The concentrations of protein in Triton X-100-soluble fraction were measured using the Lowry Protein Assay Kit (Nakarai Tesque, Inc., Kyoto, Japan) with BSA as the standard. Aliquots of 10 ml of the 0.5 mg/ml cell extract, 25 ml of L-DOPA (at a final concentration of 2.5 mM), 10 ml of various concentrations of 12815A or kojic acid (positive control), and 55 ml of phosphate buffer (100 mM, pH 6.8) were placed in each well. The assay mixture was incubated at 37°C for 1 h. After incubation, the amount of dopachrome synthesized from L-DOPA by tyrosinase was measured at 475 nm using a microplate reader (Molecular Devices).
The melanin content in B16 melanoma cells was determined as described previously 18) with a minor modification. The B16 melanoma cells were cultured continuously in DMEM medium containing 10% FBS and aMSH (10 ng/ml) for 3 d in the presence of 12815A (at final concentrations of 6.25, 12.5, 25, 50, and 100 mM) or kojic acid (at a final concentration of 300 mM). The cells were harvested by trypsinization and washed three times with ice cold PBS. The cells were counted with a hemocytometer and collected by centrifugation at 1000ϫg for 5 min. The pellets were airdried, and 200 ml of 1 N NaOH containing 10% DMSO were added to adjust the cell density to 1ϫ10 4 cells per 100 ml. The suspensions were heated at 60°C for 5 min to dissolve the melanin, and a 50 ml aliquot was diluted with 150 ml of water. The amount of melanin was determined spectrophotometrically at 500 nm using a microplate reader (Molecular Devices). The cytotoxicity of 12815A towards B16 melanoma cells was assessed using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) tetrazolium cytotoxicity assay. The cells were seeded at 2ϫ10 4 cells per well on a 96-well plate and cultured continuously in DMEM medium containing 10% FBS for 3 d in the presence of 12815A (at final concentrations of 6.25, 12.5, 25, 50, and 100 mM). The cells were then treated with MTT for 2 h. After aspiration of the medium, 200 ml of DMSO were added to dissolve the MTT-formazan reaction product and the optical density was measured at 570 nm using a microplate reader (Molecular Devices).
Stability of 12815A at Different Temperatures and pHs
In the heat stability of 12815A, the stock solution of 12815A was diluted to 100 mM with water. The diluted 12815A solution was treated with boiling water for 15 min. In the pH stability of 12815A, the pH of 12815A solution was adjusted with 1 N HCl or NaOH to the pH ranges from 2 to 10 and then was readjusted to pH 7. The tyrosinase inhibitory activities of the treated 12815A were measured by the same method of inhibitory activity towards mushroom tyrosinase as described earlier.
Statistical Analysis Data are presented as the meansϮ S.D. of triplicate measurements. Individual treatment groups were compared with the appropriate controls using the Dunnett's multiple comparison test.
RESULTS

Isolation of Active Compounds and Structure Determination
Two compounds, 12815A and B, with tyrosinase inhibitory activity were isolated from the methanol extract of the S. roseolilacinus NBRC 12815 mycelial cake. Purified samples of 6.5 mg of 12815A and 2.1 mg of 12815B were obtained from 1 l of cultured mycelial cake (Fig. 1) . The positive ESI-MS spectrum of 12815A and B showed an intense peak at m/z 218 and 184, respectively (Fig. 2) . The isolated compounds showed maximal absorptions at 221, 271, and 288 nm for 12815A, and 222, 265, and 280 nm for 12815B. Data obtained from the MS and UV spectra were consistent with those obtained for antibiotics SF 2583A and B, which have been identified as anti-nematoda compounds 14) as defined in Combined Chemical Dictionary. 19) In addition, these compounds were in total agreement about the results of SF 2583A and B using NMR analysis ( Table 1) .
Effects of Compound 12815A and B on Mushroom Tyrosinase Activity The tyrosinase inhibitors 12815A and B from S. roseolilacinus NBRC 12815 are composed of 3-methylindole and oxazole (Fig. 2B) . To investigate the activity of the related compounds, we measured the anti-tyrosinase activity of 12815A, B, 3-methylindole, oxazole, and kojic acid as a positive control. As shown in Fig. 3 , 3-methylindole and oxazole had no effect on the tyrosinase activity, while 12815A was a more potent tyrosinase inhibitor (IC 50 values about 9 mM) than 12815B (IC 50 values about 1086 mM).
Inhibitory Effects of 12815A on Mammalian Tyrosinase and on Melanin Biosynthesis in B16 Melanoma Cells
The inhibitory effects of 12815A and kojic acid on mammalian tyrosinase derived from B16 melanoma cells are shown in Fig. 4A . Compound 12815A showed potent in- The reaction mixtures consisted of L-DOPA (2.5 mM) and tyrosinase (2.5 U) in 100 mM phosphate buffer (pH 6.8). Mixtures were incubated at 25°C and measured for DOPAchrome formation using a spectrophotometer. The effects of 12815A and B, 3-methylindole, oxazole, and kojic acid (as positive control) were examined by adding each compound to the mixture prior to the addition of tyrosinase. Experiments were performed in triplicates. Error bars represent S.D.
hibitory activity against the mammalian tyrosinase in a concentration-dependent manner and was more potent than kojic acid. In addition, the 12815A inhibited melanin biosynthesis in B16 cells without affecting cell growth (Fig. 4B) . The melanin content in B16 cells was significantly reduced when exposed to concentrations of 12815A that were higher than 25 mM and was more potent than kojic acid.
Kinetic Analysis on Mushroom Tyrosinase Inhibition by 12815A The mode of inhibition of 12815A was determined using L-DOPA as a substrate. The inhibition kinetics of 12815A were analyzed by a Lineweaver-Burk plot. The three lines obtained from uninhibited enzyme and from different concentrations of 12815A intersected on the vertical axis. The Lineweaver-Burk plot shows that 12815A inhibited the tyrosinase activity in a competitive manner, with a K i value of 3.57ϫ10 Ϫ6 M and K m value of 3.8ϫ10 Ϫ7 M at 5 mM (Fig. 5) .
Effect of pHs and Temperatures on the Tyrosinase Inhibitory Activity of 12815A As shown in Fig. 6 , the tyrosinase inhibitory activity of 12815A was not inactivated by boiling for 15 min and was inactivated under acidic conditions. But 12815A exhibited partial activity with the addition of 2% Tween 80 (Fig. 7) .
DISCUSSION
Many tyrosinase inhibitors have been discovered in fungi 20, 21) and higher plants, 22, 23) however, a few melanogenesis inhibitors from Streptomyces species have been reported. 24) To study the metabolic activity of the Streptomyces strains preserved at NBRC, we performed a screen for the biological activities, including anti-tyrosinase activity, of their secondary metabolites present in these strains. 13 Among the 905 strains included in the screen, S. roseolilacinus NBRC 12815 exhibited the most potent tyrosinase inhibitory activity in vitro. The tyrosinase inhibitor was identified as SF 2583A (streptochlorin) and B [14] [15] [16] 25) based on instrumental analysis. SF 2583A has been shown to have anti-nematoda, 14) anti-angiogenic, 16 and anti-cancer 15, 25) functions. However, there is no available information regarding tyrosinase inhibi- In this study, we found that compound 12815A exhibited potent tyrosinase inhibitory activity against mushroom and mammalian tyrosinases (Figs. 3, 4A ). In addition, this compound also inhibited melanin biosynthesis in B16 melanoma cells (Fig. 4B) . A kinetic study of the inhibition of mushroom tyrosinase by 12815A showed that this compound behaved as a classical competitive inhibitor (Fig. 5) . More importantly, we found compound 12815A to be a potent tyrosinase inhibitor (IC 50 values 9 mM) as compared with 12815B (IC 50 values 1086 mM) and its components, 3-methylindole and oxazole, which do not possess any inhibitory activity. These results suggest that a chlorine atom in 12815A plays an important role in its anti-tyrosinase activity. However, the activity of 12815A was markedly decreased under acidic conditions to a level similar to that of 12815B. LC-MS analysis showed that the molecular composition of 12815A did not change under acidic conditions (not data shown). Therefore, the structural change may have occurred near a chlorine atom in 12815A. Since the inactivated 12815A exerted a partial activity when exposed to detergent, it is likely that the hydration water also plays a role in the anti-tyrosinase activity of 12815A.
The same compound as 12815A was previously isolated from the metabolites of Streptomyces sp. SF 2583 isolated from a terrestrial soil 14) and Streptomyces sp. 04DH110 isolated from marine sediment. 16) A BLAST search using the 16S ribosomal RNA (rRNA) sequences of strain 04DH110 revealed a 100% similarity to those of S. fradiae NBRC 12773 T (AB184134) and S. microsporus NBRC 13678 (AB184459). 16) S. roseolilacinus NBRC 12815 (ϭATCC 19922) is described as a subjective synonym of S. fradiae in Bergey's Manual. 26) In our previous studies, the metabolites of strain S. fradiae NBRC 13239 and NBRC 12174 exhibited potent anti-tyrosinase activity. 13) In addition, two S. fradiae strains isolated from marine environments around the Nagasaki Prefecture also exhibited potent inhibition against tyrosinase activity. 27) We found that S. fradiae with anti-tyrosinase activity isolated from Nagasaki Prefecture produced the compound 12815A by LC/MS/MS and NMR analyses (not data shown). Therefore, the ability of S. fragiae and its companions to synthesize 12815A with anti-tyrosinase activity may be common features.
S. roseolilacinus NBRC 12815 showed potent tyrosinase inhibitory activity and the activity of 12815A was found to be comparable to those of the reported tyrosinase inhibitors. 28) Although 12815A was a compound that has been known as anti-nematoda and cytotoxic agent, the anti-tyrosinase activity is a novel biological activity. The chlorine atom in 12815A and the role of the hydration water are very important in maintaining the anti-tyrosinase activity of 12815A. The 12815A may become a lead compound of tyrosinase inhibitors.
